Expression of p53 & epidermal growth factor receptor in glioblastoma

被引:6
|
作者
Karnam, Sameera
Kottu, Radhika [1 ]
Chowhan, Amit Kumar
Bodepati, Prasad Chandramouleswara
机构
[1] Sri Venkateswara Inst Med Sci, Dept Pathol, Alipiri Rd, Tirupati 517507, Andhra Pradesh, India
关键词
Epidermal growth factor receptor; glioblastoma; immunohistochemistry; p53; ASTROCYTOMA PROGRESSION; GENE AMPLIFICATION; MULTIFORME; MUTATIONS; PROTEIN; EGFR; HETEROZYGOSITY; CLASSIFICATION; POPULATION; PATHWAYS;
D O I
10.4103/ijmr.IJMR_1179_15
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: Glioblastoma (GB) is the most frequent brain tumour, manifesting at any age, with a peak incidence between 45 and 75 years. Primary and secondary GBs constitute relatively distinct disease entities in evolution, in expression profiles and in therapeutic response. Histopathologically, primary and secondary GBs are indistinguishable. The aim of this investigation was to study the immunohistochemical (IHC) expression of p53 and epidermal growth factor receptor (EGFR) in GB with the objective of categorizing the morphological variants of GB into primary and secondary based on the presence of low-grade areas and knowing the variable expression of p53 and EGFR in primary and secondary GB. Methods: A total of 28 patients with GB were studied and categorized into primary and secondary based on the presence of low-grade areas, i.e. discernible astrocytic morphology, gemistocyte and oligodendroglia. Tumours with the presence of combination of the above features or any one of the above features were taken as secondary GB, whereas tumours with highly pleomorphic areas were considered as primary GB. IHC was done on the representative tissue blocks for p53 and EGFR. Results: Majority of the patients were in the fifth and sixth decades of life with a mean age of 46.96 +/- 13 yr with male preponderance (male:female 2.5:1). Mean age of presentation was 48.93 +/- 12 yr in primary and 44.69 +/- 15 yr in secondary GB. All cases of GB were classified into primary (53.57%) and secondary (46.43%) based on morphology. EGFR was more frequently expressed than p53. Based on IHC, 50 per cent of cases were classified into primary, three per cent into secondary and 47 per cent as unclassified. Interpretation & conclusions: Histopathological features, i.e. presence of low-grade areas, may play a role in classifying GB into primary and secondary. EGFR has a pivotal role in gliomagenesis. Combination of p53 and EGFR alone may not be sufficient to clarify GB into primary and secondary.
引用
收藏
页码:738 / 745
页数:8
相关论文
共 50 条
  • [41] EXPRESSION OF AN ALTERED EPIDERMAL GROWTH-FACTOR RECEPTOR BY HUMAN GLIOBLASTOMA CELLS
    STECK, PA
    LEE, P
    HUNG, MC
    YUNG, WKA
    [J]. CANCER RESEARCH, 1988, 48 (19) : 5433 - 5439
  • [42] WILD-TYPE HUMAN P53 ACTIVATES THE HUMAN EPIDERMAL GROWTH-FACTOR RECEPTOR PROMOTER
    DEB, SP
    MUNOZ, RM
    BROWN, DR
    SUBLER, MA
    DEB, S
    [J]. ONCOGENE, 1994, 9 (05) : 1341 - 1349
  • [43] Overexpression of p53, c-erbB-2 and epidermal growth factor receptor in human breast carcinomas
    Suzuki, M
    Okuyama, T
    Yoshikawa, K
    Yamaoka, Y
    Ariyasu, T
    Fujita, M
    Tankawa, H
    Sugiyama, T
    Takahashi, R
    [J]. PATHOLOGY INTERNATIONAL, 1996, 46 (01) : 46 - 53
  • [44] Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas
    Bouvier-Labit, C
    Chinot, O
    Ochi, C
    Gambarelli, D
    Dufourt, H
    Figarella-Branger, D
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1998, 24 (05) : 381 - 388
  • [45] P53, C-ERBB-2 AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN THE BENIGN AND MALIGNANT PROSTATE
    MELLON, K
    THOMPSON, S
    CHARLTON, RG
    MARSH, C
    ROBINSON, M
    LANE, DP
    HARRIS, AL
    HORNE, CHW
    NEAL, DE
    [J]. JOURNAL OF UROLOGY, 1992, 147 (02): : 496 - 499
  • [46] Epidermal Growth Factor Receptor Mutation and p53 Overexpression during the Multistage Progression of Small Adenocarcinoma of the Lung
    Yoo, Seol Bong
    Chung, Jin-Haeng
    Lee, Hyun Ju
    Lee, Choon-Taek
    Jheon, Sanghoon
    Sung, Sook Whan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (07) : 964 - 969
  • [47] Epidermal growth factor receptor and p53 expression in T1-T2 glottic cancer involving the anterior or posterior commissure
    Rucci, L
    Bocciolini, C
    Franchi, A
    Ferlito, A
    Casucci, A
    [J]. ACTA OTO-LARYNGOLOGICA, 2004, 124 (01) : 102 - 106
  • [48] Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression
    Ohsaki, Y
    Tanno, S
    Fujita, Y
    Toyoshima, E
    Fujiuchi, S
    Nishigaki, Y
    Ishida, S
    Nagase, A
    Miyokawa, N
    Hirata, S
    Kikuchi, K
    [J]. ONCOLOGY REPORTS, 2000, 7 (03) : 603 - 607
  • [49] Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy
    Ahmed, Wael A.
    Suzuki, Kenji
    Imaeda, Yoshihiro
    Horibe, Yoshimune
    [J]. AURIS NASUS LARYNX, 2008, 35 (02) : 213 - 219
  • [50] Expression of p53, epidermal growth factor receptor, Ki-67 And O6-methylguanine-DNA methyltransferase in human gliomas
    Hui, Xinhua
    Miao, Wei
    Zou, Yuanjie
    Zhang, Wenbin
    Zhang, Yansong
    Liu, Hongyi
    [J]. ONCOLOGY LETTERS, 2013, 6 (01) : 130 - 134